Penczek Ronald W
CAO & Controller
Penczek Ronald W has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Penczek Ronald W is listed as CAO & Controller at Elevance Health, Inc. Inside the rolling window, Penczek Ronald W reported no open-market purchases and 2 open-market sales totaling $766K in ELV. The largest disclosed transaction in the window is a sale of 1,531 ELV shares on May 19, 2026, worth $617K.
Companies traded
Other insiders at ELV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$766K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Penczek Ronald W made?
Penczek Ronald W has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Penczek Ronald W trade?
Penczek Ronald W has filed SEC Form 4 disclosures for 1 company, including ELV.
When was Penczek Ronald W's most recent SEC Form 4 filing?
Penczek Ronald W's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Penczek Ronald W's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Penczek Ronald W is listed as CAO & Controller.
What is Penczek Ronald W's total buy and sell value in the current window?
Inside the rolling retention window, Penczek Ronald W bought $0 and sold $766K based on SEC Form 4 filings.
What was Penczek Ronald W's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,531 ELV shares on 2026-05-19, worth $617K, per SEC Form 4 filings.